Mkts

BioMarin Pharmaceutical Inc.

NASDAQ: BMRN
$57.35+1.32 (+2.36%)
As of Nov 9, 3:35 PM ET

Key statistics

Day range
54.7157.46
52-week range
49.2670.98
Today
Open56.73
Previous close57.35
Volume—
Valuation
Market cap10.85B
P/E ratio153.86×
EPS (TTM)-0.11
Income & risk
Dividend / yield—
Beta0.23
Avg volume2.15M
Discussion

BMRN News

Stories mentioning BMRN from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue766,208874,565776,133825,410745,145747,313745,740712,029
Cost of Goods Sold194,999275,709140,085150,090151,558136,139188,457130,459
Gross Profit571,209598,856636,048675,320593,587611,174557,283581,570
Operating Expenses
Research & Development178,796192,413409,478161,308158,731173,509184,901183,787
Sales General & Admin258,290446,207268,415232,279206,116266,607253,480263,032
Total Operating Expenses
Operating Income (Loss)129,640(44,610)(46,692)276,887223,893161,407113,893120,452
Interest Income22,56019,21017,85418,82719,01317,68018,05319,785
Interest Expense9,5712,387
Other Expense
Pretax Income141,203(27,153)(26,324)297,868238,089169,639134,441132,136
Tax Provision35,67619,4204,42057,33652,40344,69628,36124,962
Net Income (Loss)105,527(46,573)(30,744)240,532185,686124,943106,080107,174
Earnings Per Share (Basic)0.55(0.24)(0.16)1.250.970.660.560.56
Earnings Per Share (Diluted)0.54(0.24)(0.16)1.230.950.640.550.55
Weighted Average Shares Outstanding (Basic)192,497191,787192,032191,907190,967190,027190,429190,114
Weighted Average Shares Outstanding (Diluted)197,671197,394192,032197,091196,474196,708197,147200,505

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BMRN

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is a stock listed on the Nasdaq Stock Market under the ticker symbol BMRN. It last traded at $57.35 (Nov 9, 2026, 3:35 PM ET), up 2.4% on the day. That gives BioMarin Pharmaceutical a market capitalisation of $10.9B and a price-to-earnings ratio of 153.9.

Over the past 52 weeks BMRN has traded between $49.26 and $70.98.

Revenue for the quarter ended Mar 31, 2026 was $766.2M; net income $105.5M. Revenue was up 2.8% from $745.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$766.2M$105.5M13.8%
Dec 31, 2025$874.6M-$46.6M-5.3%
Sep 30, 2025$776.1M-$30.7M-4.0%
Jun 30, 2025$825.4M$240.5M29.1%

From BioMarin Pharmaceutical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…